Target Group Inc. (CBDY) stock
CBDYOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $431.92KP/E –Yield –
Target net income
Net income is the profit left for shareholders after every expense, interest and tax.
Target's net income for the twelve months ending Jun 30, 2026 was -$1.82M. For fiscal 2025 it was -$1.36M, down 947.1% from the year before. The highest annual figure on record is $272.88K in fiscal 2021.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.36M | -947.1% |
| FY2024 | Dec 31, 2024 | $160.50K | – |
| FY2023 | Dec 31, 2023 | -$323.67K | – |
| FY2022 | Dec 31, 2022 | -$4.52M | -1756.4% |
| FY2021 | Dec 31, 2021 | $272.88K | – |
| FY2020 | Dec 31, 2020 | -$7.07M | – |
| FY2019 | Dec 31, 2019 | -$10.37M | – |
| FY2018 | Dec 31, 2018 | -$1.90M | – |
| FY2017 | Dec 31, 2017 | -$1.74M | – |
| FY2016 | Dec 31, 2016 | -$2.34M | – |
| FY2015 | Dec 31, 2015 | -$2.75M | – |
| FY2014 | Dec 31, 2014 | -$358.34K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$239.81K | – |
| Q1 FY2026 | Mar 31, 2026 | -$550.36K | – |
| Q4 FY2025 | Dec 31, 2025 | -$552.31K | -355.7% |
| Q3 FY2025 | Sep 30, 2025 | -$479.39K | – |
| Q2 FY2025 | Jun 30, 2025 | -$219.77K | -133.0% |
| Q1 FY2025 | Mar 31, 2025 | -$108.21K | – |
| Q4 FY2024 | Dec 31, 2024 | $215.96K | – |
| Q3 FY2024 | Sep 30, 2024 | -$528.95K | – |
| Q2 FY2024 | Jun 30, 2024 | $666.66K | -30.8% |
| Q1 FY2024 | Mar 31, 2024 | -$193.17K | – |
| Q4 FY2023 | Dec 31, 2023 | -$184.97K | – |
| Q3 FY2023 | Sep 30, 2023 | -$356.81K | – |
| Q2 FY2023 | Jun 30, 2023 | $963.82K | +289.3% |
| Q1 FY2023 | Mar 31, 2023 | -$745.71K | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.92M | – |
| Q3 FY2022 | Sep 30, 2022 | -$286.15K | -113.0% |
| Q2 FY2022 | Jun 30, 2022 | $247.60K | -70.1% |
| Q1 FY2022 | Mar 31, 2022 | -$559.70K | – |
| Q4 FY2021 | Dec 31, 2021 | -$60.64K | – |
| Q3 FY2021 | Sep 30, 2021 | $2.20M | – |
| Q2 FY2021 | Jun 30, 2021 | $827.02K | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.69M | -195.9% |
| Q4 FY2020 | Dec 31, 2020 | -$5.36M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.92M | – |
| Q2 FY2020 | Jun 30, 2020 | -$601.37K | -208.4% |
| Q1 FY2020 | Mar 31, 2020 | $2.81M | – |
| Q4 FY2019 | Dec 31, 2019 | -$6.06M | – |
| Q3 FY2019 | Sep 30, 2019 | -$984.72K | -546.1% |
| Q4 FY2018 | Dec 31, 2018 | $554.56K | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.83M | – |
| Q2 FY2018 | Jun 30, 2018 | -$844.55K | – |
| Q1 FY2018 | Mar 31, 2018 | $220.74K | – |
| Q2 FY2017 | Jun 30, 2017 | -$56.96K | – |
| Q1 FY2017 | Mar 31, 2017 | -$549.65K | – |
| Q4 FY2016 | Dec 31, 2016 | -$94.19K | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.54M | – |
| Q4 FY2015 | Dec 31, 2015 | -$2.32M | – |
See a number that looks wrong?